These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 24239568)

  • 21. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.
    Serhan CN; Levy BD
    J Clin Invest; 2018 Jul; 128(7):2657-2669. PubMed ID: 29757195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel chemical mediators in the resolution of inflammation: resolvins and protectins.
    Serhan CN
    Anesthesiol Clin; 2006 Jun; 24(2):341-64. PubMed ID: 16927933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the use of specialized proresolving molecules in critical care offer a more focused approach to controlling inflammation than that of fish oils?
    Martindale RG; Warren MM; McClave SA
    Curr Opin Clin Nutr Metab Care; 2016 Mar; 19(2):151-4. PubMed ID: 26828585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of acute inflammation in the lung.
    Levy BD; Serhan CN
    Annu Rev Physiol; 2014; 76():467-92. PubMed ID: 24313723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
    Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
    J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments of specialized pro-resolving mediators in periodontitis.
    Liu YC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
    Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
    Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
    FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.
    Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolvin D4 attenuates the severity of pathological thrombosis in mice.
    Cherpokova D; Jouvene CC; Libreros S; DeRoo EP; Chu L; de la Rosa X; Norris PC; Wagner DD; Serhan CN
    Blood; 2019 Oct; 134(17):1458-1468. PubMed ID: 31300403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.
    Fredman G; Tabas I
    Am J Pathol; 2017 Jun; 187(6):1211-1221. PubMed ID: 28527709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
    Molfino A; Amabile MI; Monti M; Muscaritoli M
    Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation.
    Shinohara M; Serhan CN
    J Atheroscler Thromb; 2016 Jun; 23(6):655-64. PubMed ID: 27052783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?
    Serhan CN
    Am J Pathol; 2010 Oct; 177(4):1576-91. PubMed ID: 20813960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
    Duvall MG; Levy BD
    Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
    Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer.
    Babar MU; Nassar AF; Nie X; Zhang T; He J; Yeung J; Norris P; Ogura H; Muldoon A; Chen L; Libreros S
    Metabolites; 2024 May; 14(6):. PubMed ID: 38921449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.